Subchronic toxicity of Sipjeondaebo-tang (SDT) in Sprague-Dawley rats

Regulatory Toxicology and Pharmacology

Volumn 59, Issue 3, 2011, Pages 375-384

  Shin, In Sik ^a   Yu, Young Beob ^a   Seo, Chang Seob ^a   Ha, Hye Kyung ^a   Lee, Mee Young ^a   Huang, Dae Sun ^a   Kim, Jung Hoon ^a   Shin, Hyeun Kyoo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Herbal medicine; Rats; Safety; Sipjeondaebo tang (Juzen taiho to); Subchronic toxicity

Indexed keywords

5 HYDROXYMETHYLFURFURAL; ALBIFLORIN; ANGELICA GIGAS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; ATRACTYLODES JAPONICA EXTRACT; CINNAMIC ACID; CINNAMOMUM CASSIA EXTRACT; CNIDIUM OFFICINALE EXTRACT; COUMARIN; DECURSIN; FORMONONETIN; GINGER EXTRACT; GINSENG EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RC; GLYCYRRHIZA URALENSIS EXTRACT; GLYCYRRHIZIC ACID; LIQUIRITIN; PAEONIA LACTIFLORA EXTRACT; PAEONIFLORIN; PLANT EXTRACT; PORIA COCOS EXTRACT; REHMANNIA GLUTINOSA EXTRACT; SHI QUAN DA BU TANG; TESTOSTERONE; UNCLASSIFIED DRUG; ZIZYPHUS JUJUBA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SAFETY; DRUG STRUCTURE; DRUG SURVEILLANCE PROGRAM; ESTRUS CYCLE; FEMALE; FLUID INTAKE; FOOD INTAKE; HISTOPATHOLOGY; KOREAN MEDICINE; MALE; MORTALITY; NONHUMAN; OPHTHALMOSCOPY; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SEMEN ANALYSIS; TESTOSTERONE BLOOD LEVEL; TOXICITY TESTING; TREATMENT DURATION; URINALYSIS;

ANIMALS; DRUGS, CHINESE HERBAL; FEMALE; HERBAL MEDICINE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

RATTUS;

EID: 79952705359     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.09.018     Document Type: Article

References (53)

1. Bartlett M.S. Properties of sufficiency and statistical test. Proc. R. Soc. London A. 1937, 160:268-282.
2. Basch E.M., Servoss J.C., Tedrow U.B. Safety assurances for dietary supplements policy issues and new research paradigms. J. Herb. Pharmacother. 2005, 5(1):3-15.
3. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J. Gen. Int. Med. 2008, 23:854-859.
4. Boorman G.A., Eustis S.L., Elwell M.R., Montgomery Jr.C.A., Mackenzie W.F. Pathology of the Fischer Rat. Reference and Atlas 1990, Academic Press, San Diego, USA.
5. Burn C.C., Peters A., Day M.J., Mason G.J. Long-term effects of cage-cleaning frequency and bedding type on laboratory rat health, welfare, and handleability: a cross-laboratory study. Lab. Anim. 2006, 40:353-370.
6. China Market Monitoring Center (CMCC), 2010. Research report on market place development of Si quan da bu tang in 2009-2010. Available online from http://baogao.chinammn.com.cn/fzyj/63602.html.
7. Chuang W.C., Lin W.C., Sheu S.J., Chiou S.H., Chang H.C., Chen Y.P. A comparative study on commercial samples of the roots of Paeonia vitchii and P. lactiflora. Planta Med. 1996, 26(4):347-351.
8. Chung M.K., Kim J.C., Kim W.B., Kang K.K., Han S.S. Fertility study of the new pyrazolopyrimidinone derivative DA-8159 for erectile dysfunction in rats. Arzneimittelforschung 2004, 54:179-186.
9. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics 1964, 20:482-491.
10. Ferrari R., Bianchetti M.G., Sansonnens A., Frey F.J. Modulation of renal calcium handling by 11 beta-hydroxysteroid dehydrogenase type 2. J. Am. Soc. Nephrol. 2002, 13(10):2540-2546.
11. Fisher R.A. Statistical Methods for Research Workers 1970, Oliver and Boyd, Edinburgh UK. 14th ed.
12. Haranaka K., Satomi N., Sakurai A., Haranaka R., Okada N., Kobayashi M. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother. 1985, 20:1-5.
13. Haschek W.M., Rousseaux C.G. Fundamentals of Toxicologic Pathology 1998, Academic Press, San Diego.
14. Higuchi K., Shimizu Y., Yasumura T., Watanabe A. Preventive effect of liver carcinogenesis by Juzen-Taiho-To in the patients with liver cirrhosis. Liver Gall Bladder Pancreas 2002, 44:341-346.
15. JKMA (Japna Kampo Medicine Manufacturers Association). 2006. Statistics annual report on drug production. pp. 3-5.
16. Kazuhiko F., Masanori N., Takako M., Mariko I., Minako I., Yutaka Y., Mari K., Fumiatsu Y., Shinji S., Junji T., Takashi U., Ken T. IL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese Botanical Medicine Juzentaihoto. Int. J. Mol. Sci. 2008, 9:1142-1155.
17. KFDA. 2005. Guidelines for Toxicity Tests of Drugs and Related Materials Notification No. 2005-60.
18. Kim J.C., Kang B.H., Shin C.C., Kim Y.B., Lee H.S., Kim C.Y., Han J., Kim G.S., Chung D.W., Chung M.K. Subchronic toxicity of plant sterol esters administered by gavage to Sprague-Dawley rat. Food Chem. Toxicol. 2002, 40:1569-1580.
19. Kim J.C., Shin D.H., Kim S.H., Kim J.K., Park S.C., Son W.C., Lee H.S., Suh J.E., Kim C.Y., Ha C.S., Chung M.K. Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rat. Regul. Toxicol. Pharmacol. 2004, 40:356-369.
20. Kogure T., Hoshino A., Ito K., Sato H., Tatsumi T., Ohyama Y., Kawata E., Fujita K., Tamura J. Beneficial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis. Mod. Rheumatol. 2005, 15:445-449.
21. Kruskal W.H., Wallis W.A. Use of ranks in one criterion variance analysis. J. Am. Stat. Assoc. 1952, 47:614-617.
22. Lee, J.T., 2007. Research on intake of Chinese medicine by Korean, Korea Food and Drug Administration.
23. Li J., Zhang L.P., Liu W., Zhang Z.H., Liu L.J. Studies on the changes of 5-hydroxymethyl furfuraldehyde content in Radix Rehmanniae steamed for different time. Zhongguo Zhong Yao Za Zhi 2005, 30(18):1438-1440.
24. Ma J.Y., Huang D.S., Lee N.H., Ha H.K., Yu Y.B., Shin H.K. Acute toxicity study on Sipjeondaebo-tang in rats. Korean J. orient. Physiol. Pathol. 2008, 22(5):1192-1195.
25. Ma J.Y., Huang D.S., Lee N.H., Ha H.K., Yu Y.B., Shin H.K. Bacterial reverse mutation test of Sipjeondaebo-tang. J. Korean Orient. Med 2008, 29(3):1-10.
26. Ma J.Y., Huang D.S., Lee N.H., Ha H.K., Yu Y.B., Shin H.K. Chromosomalanomaly test of Sipjeondaebo-tang extract using the Chiness hamster lung. Korean J. Orient. Med. prescription 2008, 16(2):145-153.
27. Ma J.Y., Huang D.S., Lee N.H., Ha H.K., Yu Y.B., Shin H.K. Micronucleus test of Sipjeondaebo-tang extract using the bone marrow cells in ICR mice. Korean J. Orient. Med. prescription 2008, 16(1):109-115.
28. Manimaran A., Sarkar S.N., Sankar P. Toxicodynamics of subacute co-exposure to groundwater contaminant arsenic and analgesic-antipyretic drug acetaminophen in rats. Ecotoxicol. Environ. Safety 2010, 73:94-100.
29. Maruyama H., Kawamura H., Takemoto N., Komatsu Y., Aburada M., Hosoya E. Effect of Juzen-taiho-to on phagocytosis. Jpn. J. Inflamm. 1998, 8:461-465. (in Japanese).
30. Masato T., Hiroshi K., Masanori M., Hideki F., Ivan R. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kuffer cell-induced oxidative stress. Int. J. Cancer. 2008, 123:2503-2511.
31. MHLW (Ministry of Health, Labour and Welfare), 2007. Health Policy Bureau. The Status of Drug Production and Import in Japan.
32. Bedi M.K., Shenefelt P.D. Herbal therapy in dermatology. Arch. Dermatol. 2002, 138:232-242.
33. Okita K., Sakaida I., Hino K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology 2002, 62:24-28.
34. Piao X.L., Park J.H., Cui J., Kim D.H., Yoo H.H. Development of gas chromatographic/mass spectrometry-pattern recognition method for the quality control of Korean Angelica. J. Pharmacol. Biomed. Anal. 2007, 44(5):1163-1167.
35. Qi L.W., Yu Q.T., Li T., Li S.L., Wang Y.X., Sheng L.H., Yi L. Quality evaluation of Radix Astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. J. Chromatogr. A. 2006, 1134(1-2):162-169.
36. Sagara K., Oshima T., Yoshida T., Tong Y.Y., Zhang G., Chen Y.H. Determination of Cinnamomi Cortex by high-performance liquid chromatography. J. Chromatogr. 1987, 409:365-370.
37. Sasaki, K., Takasaka, H., Hirata, K., Suppressive effect of Kampo Japanese Herbal Medicine on hepatic tumor metastasis. Jpn. J. Cancer Clin. 48, 171-76.
38. Scheffe H. A method of judging all contrasts in the analysis of variance. Biometika 1953, 40:87-104.
39. Serra A., Uehlinger D.E., Ferrari P., Dick B., Frey B.M., Frey F.J., Vogt B. Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J. Am. Soc. Nephrol. 2002, 13(1):191-196.
40. Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J. Gastroentero. Hepatol. 2000, 15:84-90.
41. Shintani S., Murase H., Tsukagoshi H., Shiigar T. Glycyrrhizin (licorice)-induced hypokalemic myopathy. Report of 2 cases and review of the literature. Eur. Neurol. 1992, 32(1):44-51.
42. Sho Y., Fujisaki K., Sakashita H., Yamaguchi K., Tahara K., Kubozono O., Ido A., Tsubouchi H. Orally administrated Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J. Gastroenterol. 2004, 39:1202-1204.
43. Tagami K., Niwa K., Lian Z., Gao J., Mori H., Tamaya T. Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol. Pharm. Bull. 2004, 27:156-161.
44. Tang J.L., Liu B.Y., Ma K.W. Traditional Chinese medicine. Lancet 2008, 372:1938-1940.
45. Tsuchiya M., Kono H., Matsuda M., Fujii H., Rusyn I. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell induced oxidative stress. Int. J. Cancer. 2008, 123(11):2503-2511.
46. Utsuyama M., Seidlar H., Kitagawa M., Hirokawa K. Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice. Mech. Aging Dev. 2001, 121:341-352.
47. van Miert A.S.J.P.A.M. The use in animals of drugs licensed for human use only. Comparative Veterinary Pharmacology 1986, 489-500. Toxicology and Therapy, MTP press, Boston. A.S.J.P.A.M. van Miert, M.G. Bogaert, M. Debackere (Eds.).
48. van Rossum T.G., de Jong F.H., Hop W.C., Boomsma F., Schalm S.W. Pseudo-aldosteronism induced by intravenous glycyrrhizin treatment of chronic hepatitis Cpatients. J. Gastroentero. Hepatol. 2001, 16(7):789-795.
49. Wang P., Zhang Z., Ma X., Huang Y., Liu X., Tu P., Tong T. HDTIC-1 and HDTIC-2, two compounds extracted from Astragali Radix, delay replicative senescence of human diploid fibroblasts. Mech. Ageing Dev. 2003, 124:1025-1034.
50. Watanabe S., Imanishi J., Satoh M., Ozasa K. Unique place of Kampo (Japanese traditional medicine) in complementary and alternative medicine: a survey of doctors belonging to the regional medical association in Japan. Tohoku J. Exp. Med. 2001, 194:55-63.
51. Zhang H., Shen P., Cheng T. Identification and determination of the major constituents in traditional Chinese medicine Si-Wu-Tang by HPLC coupled with DAD and ESI-MS. J. Pharm. Biomed. Anal. 2004, 34:705-713.
52. Zhu S., Sugiyama R., Batkhuu J., Sanchir C., Komatsu K. Survey of Glycyrrhizae Radix resources in Mongolia: chemical assessment of the underground part of Glycyrrhiza uralensis and comparison with Chinese Glycyrrhizea Radix. J. Nat. Med. 2009, 63(2):137-146.
53. Zhu J.H., Wang W.Q., Tang L., Sun Y.R., Yu R.M. Comparative studies on the amount of ginsenosides between the crown galls and Chinese medicinal materials of Panax quinquefolium. Zhong Yao Cai 2009, 32(5):670-673.